Addressing Beta-Carotene In The AREDS II

By Teri Farley


Age-Related Eye Disease Study II, or AREDS II, is a study that looked at how nutrients affect eyesight. The initial study, completed in 2001, showed that high levels of antioxidants sometimes reduced the risk of developing blindness by 25 percent. There were some problems found after the study though and the subsequent study looked at those issues.

Eye diseases are some of the most debilitating. Almost a million people in the United States are blind and around 90% of these are elderly. There are several different reasons someone might end up with an eye disease. Some people are born blind due to defects during the gestation period. Others are caused by diabetes or eye injury. However, most appear to be associated with aging, such as age-related macular degeneration (AMD) and cataracts.

There are treatments available but they are limited in their effectiveness and are only good for a certain range of disease. One of these is laser surgery; this is effective in reducing the threat of blindness. However, it is also too expensive for many people and it comes with some of its own hazards. Normally the side effects are not serious, however, they are common. These include reduced night vision and loss of peripheral vision as well as a worsening of visual acuity and sometimes eye hemorrhages.

AREDS, the initial Age-Related Eye Disease Study was finished and released in 2001. This study was begun to review risk factors and history associated with cataracts and AMD. Another purpose was to analyze whether higher doses of antioxidants might affect AMD or cataracts. They looked at a combination of vitamin C, vitamin E, zinc, and beta-carotene.

In the first study, the researchers found that a high level of antioxidants could reduce the possibility of blindness in high risk individuals by about 25 percent. High risk individuals were those who either already had intermediate AMD or AMD in only one of their eyes. However, one ingredient of the original formula was beta-carotene, which has been linked to an increase in risk of lung cancer for smokers. Additionally, there was no effect on cataracts.

In May 2013, the results of the second study were released. One research goal of this study was to determine whether there was a good substitute for the beta-carotene that was used for the initial formula. Researchers found that two antioxidants, zeaxanthin and lutein, were effective substitutes for the beta-carotene and did not reduce the effectiveness. This is important news for high risk AMD individuals who are interested in trying this formula.

A lot of the elderly are already on various prescriptions. In addition to this they may use over-the-counter drugs or supplements. The high-dose supplements in this combination could interfere or cause some of these medications to lose their effectiveness.

There are definitely beneficial effects of laser surgery although this is expensive and can have complications. A safer alternative may be the formulation developed in the AREDS II study. The study confirmed that high levels of zinc and antioxidants reduced the risk of AMD. The study further showed that lutein and zeaxanthin could be substituted for beta-carotene with no reduction in benefits. Of course, before using any medication you should always consult your doctor.




About the Author:



0 commentaires:

Enregistrer un commentaire